サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1668158

スポーツ医学向け血液ベースバイオマーカー市場- 世界の産業規模、動向、機会、予測、タイプ別、地域別、競合別、2020～2030年

Blood-based Biomarker For Sports Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Region & Competition, 2020-2030F

出版日
ページ情報
英文 187 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

スポーツ医学向け血液ベースバイオマーカー市場- 世界の産業規模、動向、機会、予測、タイプ別、地域別、競合別、2020～2030年
出版日: 2025年02月28日
発行: TechSci Research
ページ情報: 英文 187 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

スポーツ医学向け血液ベースバイオマーカーの世界市場は、2024年に7億5,845万米ドルと評価され、予測期間中のCAGRは5.66%で、2030年には10億5,772万米ドルに達すると予測されています。

医療診断の進歩により、個別化された正確なアスリートケアの需要が高まるにつれて、スポーツ医学向け血液ベースバイオマーカー市場は世界的に急成長を遂げています。血液ベースバイオマーカーは、アスリートの生理学的状態、傷害リスク、回復の進捗状況をリアルタイムで把握できることから、スポーツ医学の分野で支持を集めています。タンパク質、代謝物、遺伝子マーカーを含むこれらのバイオマーカーは、アスリートのパフォーマンスと健康の様々な側面をモニタリングする非侵襲的かつ客観的な手段を提供します。市場成長の主な促進要因のひとつは、スポーツ関連傷害の発生率の増加です。プロやアマチュアのアスリートが最高のパフォーマンスを発揮しようと努力するにつれ、筋緊張、靭帯断裂、脳震盪などの傷害が一般的になっています。血液ベースのバイオマーカーは、組織損傷、炎症、ストレスに関連した状態の早期発見を可能にし、回復を促進し、さらなる合併症を予防するタイムリーな介入を可能にします。さらに、個別化されたスポーツ医療が重視されるようになったことで、個人特有の生理学的反応に基づくオーダーメイドのトレーニングやリハビリテーション計画が可能になり、バイオマーカーの採用に拍車がかかっています。

市場概要
予測期間 2026～2030年
市場規模：2024年 7億5,845万米ドル
市場規模：2030年 10億5,772万米ドル
CAGR：2025～2030年 5.66%
急成長セグメント クレアチンキナーゼ（CK）
最大市場 北米

バイオテクノロジーとバイオマーカー探索の進歩も市場を前進させています。クレアチンキナーゼ（CK）や乳酸デヒドロゲナーゼ（LDH）のような筋損傷の指標から、C反応性タンパク質（CRP）やインターロイキンのような酸化ストレスや炎症のマーカーまで、新規バイオマーカーの継続的な研究によって測定可能なパラメータの範囲が広がっています。これらの技術革新は、診断精度を向上させるだけでなく、ウェアラブル検査機器やポイントオブケア検査機器を通じてリアルタイムのモニタリングを容易にし、市場の需要をさらに押し上げています。

主な市場促進要因

スポーツ傷害の増加と早期発見の必要性

主な市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のスポーツ医学向け血液ベースバイオマーカー市場に与える影響

第5章 世界のスポーツ医学向け血液ベースバイオマーカー市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別（CK、ミオグロビン、乳酸、白血球数、尿素、CRP、脂質およびタンパク質ヒドロペルオキシド、IL-6、その他）
    • 地域別
    • 企業別（2024年）
  • 市場マップ

第6章 北米のスポーツ医学向け血液ベースバイオマーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州のスポーツ医学向け血液ベースバイオマーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域のスポーツ医学向け血液ベースバイオマーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米のスポーツ医学向け血液ベースバイオマーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのスポーツ医学向け血液ベースバイオマーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収（ある場合）
  • 製品の発売（ある場合）
  • 最近の動向

第13章 世界のスポーツ医学向け血液ベースバイオマーカー市場：SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Abbott Laboratories
  • BIOMERIEUX
  • F. Hoffmann-La Roche Ltd.
  • ARUP Laboratories Inc.
  • Siemens Healthineers AG
  • RayBiotech, Inc
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc
  • Beckman Coulter, Inc.
  • Randox Laboratories Ltd.

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 27717

Global Blood-based Biomarker For Sports Medicine Market was valued at USD 758.45 Million in 2024 and is expected to reach USD 1057.72 Million by 2030 with a CAGR of 5.66% during the forecast period. The global blood-based biomarker market for sports medicine is experiencing rapid growth as advancements in medical diagnostics drive the demand for personalized and precise athlete care. Blood-based biomarkers have gained traction in the field of sports medicine due to their ability to provide real-time insights into an athlete's physiological status, injury risks, and recovery progress. These biomarkers, which include proteins, metabolites, and genetic markers, offer a non-invasive and objective means of monitoring various aspects of athletic performance and health. One of the primary drivers of market growth is the increasing incidence of sports-related injuries. As professional and amateur athletes strive for peak performance, injuries such as muscle strains, ligament tears, and concussions have become common. Blood-based biomarkers enable early detection of tissue damage, inflammation, and stress-related conditions, allowing for timely interventions that can enhance recovery and prevent further complications. Additionally, the growing emphasis on personalized sports medicine has fueled the adoption of these biomarkers, as they enable tailored training and rehabilitation plans based on an individual's unique physiological responses.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 758.45 Million
Market Size 2030USD 1057.72 Million
CAGR 2025-20305.66%
Fastest Growing SegmentCreatine Kinase (CK)
Largest MarketNorth America

Advancements in biotechnology and biomarker discovery have also propelled the market forward. Continuous research into novel biomarkers has expanded the range of measurable parameters, from muscle damage indicators like creatine kinase (CK) and lactate dehydrogenase (LDH) to markers of oxidative stress and inflammation, such as C-reactive protein (CRP) and interleukins. These innovations are not only improving diagnostic accuracy but also facilitating real-time monitoring through wearable and point-of-care testing devices, further driving market demand.

Key Market Drivers

Rising Sports Injuries and Need for Early Detection

The increasing incidence of sports injuries across all levels of athletic participation is a major driver for the global blood-based biomarker for the sports medicine market. Athletes, both professional and amateur, are experiencing rising cases of muscle tears, ligament injuries, concussions, and stress fractures due to the growing intensity and competitiveness in sports. Traditional diagnostic methods, such as imaging techniques and physical assessments, often fail to detect early signs of damage, leading to delayed treatment and prolonged recovery periods. This has fueled the demand for blood-based biomarkers, which offer a minimally invasive and highly accurate means of detecting physiological and biochemical changes associated with sports-related injuries. According to the National Safety Council, in 2023, approximately 3.7 million individuals received emergency medical treatment for injuries related to sports and recreational equipment. The activities most commonly linked to these injuries include exercise, cycling, and basketball. One of the key advantages of blood-based biomarkers in sports medicine is their ability to provide early detection of injuries such as concussions and muscle damage. Biomarkers such as creatine kinase (CK), myoglobin, and C-reactive protein (CRP) can indicate muscle stress, inflammation, and tissue breakdown, allowing medical professionals to intervene before severe damage occurs. In addition, neuro biomarkers like S100 calcium-binding protein B (S100B) and tau protein are gaining attention for their role in detecting mild traumatic brain injuries (TBIs) in athletes, particularly in contact sports such as football, boxing, and rugby. The ability of these biomarkers to detect even subtle injuries has increased their adoption in sports medicine, as they facilitate personalized treatment plans and prevent long-term complications.

Key Market Trends

Technological Advancements

The blood-based biomarker for sports medicine market is witnessing significant growth, driven primarily by advancements in technology. These innovations are reshaping how biomarkers are detected, analyzed, and utilized in sports medicine to enhance athlete performance, injury prevention, and recovery monitoring. With the integration of cutting-edge diagnostic tools, artificial intelligence (AI), and wearable biosensors, the landscape of sports medicine is undergoing a transformation, making blood-based biomarkers more efficient and accessible. One of the major breakthroughs in this field is the development of high-sensitivity detection techniques, such as next-generation sequencing (NGS), mass spectrometry, and microfluidic platforms. These technologies have enhanced the precision of biomarker identification, allowing for early detection of muscle fatigue, inflammation, and potential injuries. NGS, for instance, enables comprehensive genomic and proteomic analysis from small blood samples, providing detailed insights into an athlete's physiological state. Similarly, mass spectrometry has improved the accuracy of biomarker quantification, leading to more reliable assessments of biochemical changes associated with sports-related stress and injuries.

Key Market Players

  • Abbott Laboratories
  • BIOMERIEUX
  • F. Hoffmann-La Roche Ltd.
  • ARUP Laboratories Inc.
  • Siemens Healthineers AG
  • RayBiotech, Inc
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc
  • Beckman Coulter, Inc.
  • Randox Laboratories Ltd.

Report Scope

In this report, the Global Blood-based Biomarker For Sports Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood-based Biomarker For Sports Medicine Market, By Type:

  • CK
  • Myoglobin
  • Lactate
  • WBC
  • Urea
  • CRP
  • Lipid and Protein Hydroperoxides
  • IL-6
  • Others

Blood-based Biomarker For Sports Medicine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood-based Biomarker For Sports Medicine Market.

Available Customizations:

Global Blood-based Biomarker For Sports Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Blood-based Biomarker For Sports Medicine Market

5. Global Blood-based Biomarker For Sports Medicine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America Blood-based Biomarker For Sports Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood-based Biomarker For Sports Medicine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
    • 6.3.2. Mexico Blood-based Biomarker For Sports Medicine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
    • 6.3.3. Canada Blood-based Biomarker For Sports Medicine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End Use

7. Europe Blood-based Biomarker For Sports Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
    • 7.3.2. Germany Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
    • 7.3.3. United Kingdom Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
    • 7.3.4. Italy Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
    • 7.3.5. Spain Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type

8. Asia Pacific Blood-based Biomarker For Sports Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
    • 8.3.2. India Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
    • 8.3.3. South Korea Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
    • 8.3.4. Japan Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
    • 8.3.5. Australia Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type

9. South America Blood-based Biomarker For Sports Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Blood-based Biomarker For Sports Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
    • 9.3.2. Argentina Blood-based Biomarker For Sports Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
    • 9.3.3. Colombia Blood-based Biomarker For Sports Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type

10. Middle East and Africa Blood-based Biomarker For Sports Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Blood-based Biomarker For Sports Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
    • 10.3.2. Saudi Arabia Blood-based Biomarker For Sports Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
    • 10.3.3. UAE Blood-based Biomarker For Sports Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood-based Biomarker For Sports Medicine Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. BIOMERIEUX
  • 15.3. F. Hoffmann-La Roche Ltd.
  • 15.4. ARUP Laboratories Inc.
  • 15.5. Siemens Healthineers AG
  • 15.6. RayBiotech, Inc
  • 15.7. Thermo Fisher Scientific, Inc.
  • 15.8. Bio-Rad Laboratories, Inc
  • 15.9. Beckman Coulter, Inc.
  • 15.10. Randox Laboratories Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer